FREE Case Review (866) 588-0600

What Types of Cancer are Linked to Belviq?

A recent study found that the widely-prescribed weight-loss drug Belviq (generic: lorcaserin) was linked to an increased risk for cancer. As a result, the FDA requested that Eisai Inc. recall Belviq from the U.S. market. The study identified several types of cancers, but a few were the most common.
Award Logos
Awards & recognition
C.L. Mike Schmidt Published by C.L. Mike Schmidt
Free Confidential Lawsuit Review
If you or a loved one was injured, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help. Please click the button below for a Free Confidential Case Evaluation or call our law firm toll-free 24 hrs/day by dialing (866) 588-0600.

Start My Free Case Review

Cancer Risks Most Associated With Belviq

Belviq was recalled following the FDA’s review of the CAMELLIA-TIMI 61 clinical trial [1], which found more cancer diagnoses among Belviq users compared to patients who took a placebo. Imbalances in specific cancers including pancreatic cancer, colorectal cancer, and lung cancer contributed to the observed overall imbalance in cancer cases identified by the study, according to the FDA.

Although these were the most common cancers, they were not the only types. Patients received a variety of cancer diagnoses over the course of the 5-year trial.

Related ArticleBelviq (Lorcaserin) Lawsuit Update

How Does Belviq Work?

Belviq works to control appetite by activating serotonin receptors in the brain. Serotonin is a neurotransmitter that triggers feelings of well-being such as satisfaction, gratification, and being fully fed.

Most patients take regular versions of Belviq tablets twice per day. Extended-release tablets are taken only once per day. Belviq users are supposed to lose 5% of their body weight during the first 12 weeks of initiating treatment when used in conjunction with exercise and a healthy diet.

What are the Side Effects of Belviq?

In addition to being linked to an increased risk for cancer, Belviq has been linked to other, more moderate side effects including:

  • Nausea
  • Dry mouth
  • Headache
  • Dizziness
  • Constipation
  • Tiredness

Talk to your doctor immediately if you have any of these side effects after taking Belviq.

Related Article: Why was Belviq Taken Off the Market?

Are Lawsuits Being Filed Against Belviq Manufacturers?

Victims of cancer are currently in the process of filing lawsuits against Eisai Inc., the manufacturer of Belviq, stating that using the medication led to their illness. These actions bring several accusations against the company, including the failure to conduct proper research of Belviq and Belviq XR side effects before releasing the drug, failure to publicly acknowledge the link between Belviq and cancer, and the intentional postponement of recalling it from the U.S. market.

Related Article: Should You File a Belviq Lawsuit?

What To Do if You Got Cancer After Taking Belviq

If you or a loved one was diagnosed with cancer after taking Belviq, you may be entitled to financial compensation for your injuries. Since the FDA released data from the CAMELLIA-TIMI 61 clinical trial, patients have started filing lawsuits against Eisai Inc.

Don’t wait to take action if you’ve been harmed. If you have cancer and took Belviq, contact the experienced defective drugs lawyers at Schmidt & Clark, LLP, today. Although lung cancer, pancreatic cancer, and colorectal cancer were most common in the study, any cancer diagnosis could qualify.

FAQs

How was the link between Belviq and cancer discovered?

The link between Belviq and cancer was discovered through post-marketing clinical studies and reports, which indicated a higher incidence of certain cancers among users of the drug compared to those taking a placebo.

What should I do if I have taken Belviq and am concerned about cancer risk?

If you have taken Belviq and are concerned about cancer risk, consult with your healthcare provider for a medical evaluation and discuss any potential symptoms or screening options. It’s also advisable to stay informed about ongoing research and findings.

Who can file a lawsuit related to Belviq and cancer?

Individuals who have developed cancer after taking Belviq can file a lawsuit against the manufacturer. Consulting with a personal injury lawyer specializing in pharmaceutical litigation can help determine eligibility and guide the legal process.

What evidence is needed to support a Belviq cancer lawsuit?

Evidence needed includes medical records documenting the cancer diagnosis, proof of Belviq use, and any related costs or damages incurred due to the medication. Expert testimony linking the drug to the cancer may also be necessary.

Related Articles:

See the other dangerous drug lawsuits we’ve taken on.

Choose our lawyers

Have you or a loved one suffered from the adverse side effects caused by defective medication?

Get a Free Lawsuit Evaluation With Our Lawyers

The Pharmaceutical Litigation Group at Schmidt & Clark, LLP law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.

If you or a loved one got cancer after taking Belviq, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.